Paired Primary and Recurrent Rhabdoid Meningiomas: Cytogenetic Alterations, BAP1 Gene Expression Profile and Patient Outcome.

Autor: Garrido Ruiz, Patricia Alejandra, Rodriguez, Álvaro Otero, Corchete, Luis Antonio, Zelaya Huerta, Victoria, Pasco Peña, Alejandro, Caballero Martínez, Cristina, González-Carreró Fojón, Joaquín, Catalina Fernández, Inmaculada, López Duque, Juan Carlos, Zaldumbide Dueñas, Laura, Mosteiro González, Lorena, Astudillo, María Aurora, Hernández-Laín, Aurelio, Camacho Urkaray, Emma Natalia, Viguri Diaz, María Amparo, Orfao, Alberto, Tabernero, María Dolores

Publikováno v: Biology (2079-7737); May2024, Vol. 13 Issue 5, p350, 18p

Comparación Morfométrica de Biopsias y Citobloques en Patología Tumoral de Pulmón: Estudio piloto

Autor: Eguizábal Martínez, Elena

Publikováno v: Addi. Archivo Digital para la Docencia y la Investigación
instname

[ES] La mayoría de las neoplasias pulmonares se detectan en estadios avanzados no quirúrgicos y para su diagnóstico, en la gran mayoría de los casos, únicamente se dispone de muestras de pequeño tamaño, ya sean biopsias o citologías. Las guí

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3fc12acd7752342ce479b28ae9eb48f2
http://hdl.handle.net/10810/54643

Mutational profiling can identify laryngeal dysplasia at risk of progression to invasive carcinoma.

Autor: Manterola L; Molecular Oncology Group, Biodonostia Research Institute, San Sebastián, Gipuzkoa, Spain., Aguirre P; Department of Pathology, Donostia University Hospital, San Sebastián, Gipuzkoa, Spain., Larrea E; Molecular Oncology Group, Biodonostia Research Institute, San Sebastián, Gipuzkoa, Spain., Arestín M; Molecular Oncology Group, Biodonostia Research Institute, San Sebastián, Gipuzkoa, Spain., Gaafar A; Department of Pathology, Cruces University Hospital, Barakaldo, Bizkaia, Spain., Elorriaga K; Department of Pathology, Onkologikoa, San Sebastian, Gipuzkoa, Spain., Goicoechea I; Molecular Oncology Group, Biodonostia Research Institute, San Sebastián, Gipuzkoa, Spain., Armesto M; Molecular Oncology Group, Biodonostia Research Institute, San Sebastián, Gipuzkoa, Spain., Fernández-Mercado M; Molecular Oncology Group, Biodonostia Research Institute, San Sebastián, Gipuzkoa, Spain., Zabalza I; Department of Pathology, Galdakao-Usansolo Hospital, Galdakao, Bizkaia, Spain., López-Duque JC; Department of Pathology, Basurto University Hospital, Bilbao, Bizkaia, Spain., Larruskain E; Department of Otolaryngology, Donostia University Hospital, San Sebastián, Gipuzkoa, Spain., Sistiaga JA; Department of Otolaryngology, Donostia University Hospital, San Sebastián, Gipuzkoa, Spain., Landa M; Department of Otolaryngology, Donostia University Hospital, San Sebastián, Gipuzkoa, Spain., Zabala A; Department of Otolaryngology, Basurto University Hospital, Bilbao, Bizkaia, Spain., Santaolalla F; Department of Otolaryngology, Basurto University Hospital, Bilbao, Bizkaia, Spain., Municio JA; Department of Otolaryngology, Cruces University Hospital, Barakaldo, Bizkaia, Spain., Ispizua Á; Department of Otolaryngology, Donostia University Hospital, San Sebastián, Gipuzkoa, Spain., García-Pedrero JM; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto Universitario de Oncología del Principado de Asturias, University of Oviedo, CIBERONC, Oviedo, Asturias, Spain., Rodrigo JP; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto Universitario de Oncología del Principado de Asturias, University of Oviedo, CIBERONC, Oviedo, Asturias, Spain., Lawrie CH; Molecular Oncology Group, Biodonostia Research Institute, San Sebastián, Gipuzkoa, Spain. charles.lawrie@biodonostia.org.; Radcliffe Department of Medicine, University of Oxford, Oxford, UK. charles.lawrie@biodonostia.org.; IKERBASQUE, Basque Foundation for Science, Bilbao, Bizkaia, Spain. charles.lawrie@biodonostia.org.

Publikováno v: Scientific reports [Sci Rep] 2018 Apr 26; Vol. 8 (1), pp. 6613. Date of Electronic Publication: 2018 Apr 26.